Keros Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGKeros Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 14), showing significant lag compared to the market leaders. Earnings growth of 67% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $11.47 | +1.45% | ABOVE |
| 50 SMA | $11.68 | -0.38% | BELOW |
| 100 SMA | $15.16 | -23.23% | BELOW |
| 150 SMA | $15.68 | -25.76% | BELOW |
| 200 SMA | $15.51 | -24.97% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is KROS in an uptrend right now?
KROS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is KROS overbought or oversold?
KROS's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is KROS outperforming the market?
KROS has a Relative Strength (RS) Rating of 14 out of 99. KROS is currently lagging the broader market.
Where is KROS in its 52-week range?
KROS is trading at $11.64, which is 52% of its 52-week high ($22.55) and 10% above its 52-week low ($10.41).
How volatile is KROS?
KROS has a Beta of 1.03 and 52-week volatility of 45%. It's more volatile than the S&P 500 - expect bigger swings.